Skip to content

Screening and setting up a novel evaluation system of biological indexes to evalute the severity and prognosis of patients with acute pancreatitis in early stage

Screening and setting up a novel evaluation system of biological indexes to evalute the severity and prognosis of patients with acute pancreatitis in early stage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-15005864
Enrollment
Unknown
Registered
2014-12-14
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

Gold Standard:
Index test:

Sponsors

Department of Integrated Traditional and Western Medicine, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 18 and 70 years old; 2. Confirmed diagnosis of acute pancreatitis; 3. Within 72h after the onset of abdominal pain; 4. Informed consent obtained from all patients or their legal representatives prior to randomization.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactation women; 2. Combined with any tumors; 3. Combined with any end-stage comorbidities; 4. Participating in clinical trials which may affect the results of this trial.

Design outcomes

Primary

MeasureTime frame
Blood biochemical indexes;Severity indexes;Biological indexes;Terminal indexes;

Countries

China

Contacts

Public ContactLihui Deng
lisadeng1981@gmail.com+86 13608036360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026